Acute dystonia associated with aripiprazole in a child [4]

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 46, Issue 3, 2007, Pages 306-307

  Singh, Manpreet K ^a   DelBello, Melissa P ^b   Adler, Caleb M ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ARIPIPRAZOLE; BENZATROPINE; GUANFACINE; QUETIAPINE; VALPROATE SEMISODIUM;

AGGRESSION; BIPOLAR DISORDER; CASE REPORT; CHILD PSYCHIATRY; CLINICAL EXAMINATION; CLINICAL FEATURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSTONIA; HUMAN; LETTER; MALE; MENTAL INSTABILITY; NECK PAIN; PRIORITY JOURNAL; SCHOOL CHILD; SENSATION; SIDE EFFECT; TREATMENT OUTCOME;

ACUTE DISEASE; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CHILD; DYSTONIA; HUMANS; MALE; PIPERAZINES; QUINOLONES; RECEPTORS, DOPAMINE D2;

EID: 33847218939     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/chi.0b013e31802ed925     Document Type: Letter

References (5)

1. Burris KD, Molski TF, Xu C et al. (2002), Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther 302:381-389
2. Ghaemi SN, Hsu DJ, Rosenquist KJ, Pardo TB, Goodwin FK (2006), Extrapyramidal side effects with atypical neuroleptics in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 30:209-213
3. Kane JM, Carson WH, Saha AR et al. (2002), Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder. J Clin Psychiatry 63:763-771
4. Lindsey RL, Kaplan D, Koliatos V, Walters JK, Sandson NB (2003), Aripiprazole and extrapyramidal symptoms. J Am Acad Child Adolesc Psychiatry 42:1268-1269
5. Rugino TA, Janvier YM (2005), Aripiprazole in children and adolescents: clinical experience. J Child Neurol 20:603-610